Research published recently in Science as Culture suggests that men are surprisingly positive and open to the concept of having cancer-detecting biosensors implanted within their bodies – effectively making them cyborgs.
Such auto biotechnologies can aid in the treatment or repair of tissue and organs without external human direction or control. They represent version 2.0 of cyborgs as originally invented by Clynes and Kline in the early 1960’s, referred to as the bodily adaptations required by individuals to live in outer space. Since then, science and technology have made giant leaps forward, leading to the innovative concept of ‘everyday cyborgs’, now increasingly forming an integral part of our reality.
Cyborgs are common in science fiction and are traditionally perceived as lacking emotion and human feeling. ‘Everyday cyborgs’ however, are real people who just happen to live with highly sophisticated devices – devices which could save lives.
In the article ‘Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer ’ lead author Gill Haddow explores the phenomenon, portraying a new version of cyborg that goes beyond the traditional science-fiction monster stereotype we are used to. Haddow argues that biosensors are the key devices that differentiate a cyborg from default human beings, sensing when cancer tumours, present in organs such as the prostate, will be most vulnerable to radiotherapy.
Investigating opinions on such devices, by interviewing a dozen men recovering from prostate cancer, threw up surprisingly positive and open views. Biosensors were well received and the men interviewed felt that the devices might even be used as a long-term warning system, alerting doctors when a cancer might have returned and potentially delivering drug therapy. As reported by Haddow: “Any possible malfunctioning of the device was a risk worth taking as it was better to be cyborg than a ‘leaker and a bleeder’ – a crude term referring to the spoiled masculine identity that can be caused by prostate cancer”.
The study suggested that having cancer increased the willingness of the individual to try anything, even life as a cyborg. In light of that, the everyday cyborg becomes neither a monster nor a future space-traveller but, in this case, a man sick and vulnerable prepared to fight for his life with an implanted device.
Learn more: Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer
The Latest on: Biosensor
No news articles
via Google News
The Latest on: Biosensor
- LSU biological sciences fellow, mechanical engineering professor create sensor to detect COVID-19on January 21, 2021 at 9:15 am
An LSU Biological Sciences postdoctoral research fellow and LSU mechanical engineering assistant professor are working together to create a smartphone-based biosensor device for detecting SARS-CoV-2 ...
- AI-Based Technique May Detect Prostate Cancer From Urineon January 21, 2021 at 7:25 am
Prostate cancer is one of the most common cancers among men. A novel Artificial Intelligence (AI)-based technique may help in diagnosing prostate cancer from urine within only twenty minutes with ...
- NCDC approves SD Biosensor, Abbott rapid test kitson January 20, 2021 at 12:03 am
The Federal Government has approved two Rapid Diagnostic Test (RDTs) kits manufactured by SD Biosensor and Abbott for covid-19 testing.
- NIH increases PhysIQ contract to $6.6Mon January 19, 2021 at 10:59 am
PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker.
- The Biosensor Market To Witness A Substantial Demand Amidst Covid-19, To Reach US$ 22,551.2 Millionon January 19, 2021 at 3:18 am
Biosensor Market Market Value – US$ 22,551.2 Mn in 2021 Market CAGR Value – 9.7% in 2021 Market Forecast Year – 2020 to 2030 Get Sample Copy of This Report -> Click Here Read Full Press Release ...
- Glucose Biosensor Market Orientation, Forecast To 2030 and Improvement | Roche AG, Bayer AGon January 18, 2021 at 2:49 pm
Pune, Maharashtra, India, January 18 2021 (Wiredrelease) MarketResearch.Biz –:An extensive and elaborate primary research on Global Glucose Biosensor Market report sheds light on numerous facets ...
- PhysIQ Recognized as a 2021 Hottest Health Tech Companyon January 15, 2021 at 12:57 am
The Observer names physIQ as one of the hottest tech companies in the US second straight year for outstanding work amid the global COVID-19 pandemic. (Photo: Business Wire) In early 2020, physIQ ...
- Texas A&M students create a rapid COVID-19 test prototype using biosensor technologyon January 14, 2021 at 10:04 pm
News Highlights: Texas A&M students create a rapid COVID-19 test prototype using biosensor technology COLLEGE STATION, Texas (KBTX) - Four Texas A&M ...
- Texas A&M students create rapid COVID-19 test prototype using biosensor technologyon January 13, 2021 at 4:00 pm
COLLEGE STATION, Texas (KBTX) - Four Texas A&M biomedical engineering students teamed up to create a prototype for a rapid COVID-19 test that uses a biosensor. At the outset of the pandemic ...
- Biosensor Market by Key Players, Product and Production Information analysis and forecast to 2026on January 9, 2021 at 3:59 pm
The scope of the report includes a detailed study of global and regional markets on Global Biosensor Market with the reasons given for variations in the growth of the industry in certain regions.
via Bing News